Clinical Trial Update: Fibrosis-Modulating Effects of Metformin and Pirfenidone in Oral Submucous Fibrosis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trials are evaluating the fibrosis-modulating effects of metformin and pirfenidone in oral submucous fibrosis, with the study status showing completio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Submucous Fibrosis

Drugs mentioned

• PIRFENIDONE (pirfenidone)
• metformin (metformin)

Snippet

Sponsor: Ziauddin University | Conditions: Oral Submucous Fibrosis | Phase 1, Phase 2 | Status: COMPLETED